YIN Yicong, YU Songlin, YU Jialei, WANG Danchen, MA Chaochao, ZOU Yutong, XIE Shaowei, CHENG Qian, QIU Ling. Quantification of Human Plasma 18-Hydroxycorticosterone by Isotope Dilution Ultra Performance Liquid Chromatography Tandem Mass Spectrometry[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(4): 510-517. DOI: 10.12290/xhyxzz.2021-0301
Citation: YIN Yicong, YU Songlin, YU Jialei, WANG Danchen, MA Chaochao, ZOU Yutong, XIE Shaowei, CHENG Qian, QIU Ling. Quantification of Human Plasma 18-Hydroxycorticosterone by Isotope Dilution Ultra Performance Liquid Chromatography Tandem Mass Spectrometry[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(4): 510-517. DOI: 10.12290/xhyxzz.2021-0301

Quantification of Human Plasma 18-Hydroxycorticosterone by Isotope Dilution Ultra Performance Liquid Chromatography Tandem Mass Spectrometry

Funds: 

Beijing Key Clinical Specialty for Laboratory Medicine-Excellent Project ZK201000

More Information
  • Corresponding author:

    QIU Ling  Tel: 86-10-69159712, E-mail: lingqiubj@163.com

  • Received Date: March 30, 2021
  • Accepted Date: June 14, 2021
  • Issue Publish Date: July 29, 2021
  •   Objective  To establish a method for quantification of 18-Hydroxycorticosterone (18-OHB) in plasma by isotope dilution ultra performance liquid chromatography tandem mass spectrometry (ID-UPLC-MS/MS).
      Methods  This study was a methodology-validation on the evaluation of plasma 18-OHB with LC-MS/MS. Two hundreds microliter(μL) of serum samples or standard solution were mixed with 18-OHB-d4 (internal standard) and treated with methanol solution to precipitate protein and anion-exchange solID-phase extraction(SPE). After SPE, the eluates were detected in the positive electro-spray ionization mode and multiple reaction-monitor mode. The precision, recovery, lower limits of quantification, linearity and the matrix-effect of LC-MS/MS have been evaluated. Since November 2019, healthy participants were recruited continuously to the study to validate the reference intervals of Mayo Clinical Laboratory.
      Results  The analyzing time was 3.0 min. The repeatability coefficient of variation and laboratory imprecision for detecting low, medium and high levels of 18-OHB were 2.2%-3.5% and 3.7%-5.0%, respectively. The average recovery of 18-OHB ranged between 98.1% and 101.7%.The lower limit of quantification was 0.1 μg/L. The matrix of plasma had no significant effect on the measurement of 18-OHB. The 2.5th to 97.5th percentiles of 18-OHB measured by ID-UPLC-MS/MS in apparently healthy population was 0.01 and 0.60 μg/L, The plasma level of 18-OHB is outside the reference range provided by the Mayo Medical Laboratory Center in 66%(48/73) of the population.
      Conclusions  A reliable and specific LC-MS/MS method for evaluating plasma 18-OHB was established in the clinical laboratory. The method was simple, rapid and suitable for the diagnosis and classification of primary aldosteronism.
  • [1]
    Savard S, Amar L, Plouin PF, et al. Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study[J]. Hypertension, 2013, 62: 331-336. DOI: 10.1161/HYPERTENSIONAHA.113.01060
    [2]
    Nanba AT, Nanba K, Byrd JB, et al. Discordance between imaging and immunohistochemistry in unilateral primary aldosteronism[J]. Clin Endocrinol (Oxf), 2017, 87: 665-672. DOI: 10.1111/cen.13442
    [3]
    Wu VC, Yang SY, Lin JW, et al. Kidney impairment in primary aldosteronism[J]. Clin Chim Acta, 2011, 412: 1319-1325. DOI: 10.1016/j.cca.2011.02.018
    [4]
    Nwariaku FE, Miller BS, Auchus R, et al. Primary hyperaldosteronism: effect of adrenal vein sampling on surgical outcome[J]. Arch Surg, 2006, 141: 497-503. DOI: 10.1001/archsurg.141.5.497
    [5]
    Young WF, Stanson AW, Thompson GB, et al. Role for adrenal venous sampling in primary aldosteronism[J]. Surgery, 2004, 136: 1227-1235. DOI: 10.1016/j.surg.2004.06.051
    [6]
    Kawamoto T, Mitsuuchi Y, Toda K, et al. Role of steroid 11 beta-hydroxylase and steroid 18-hydroxylase in the biosyn-thesis of glucocorticoids and mineralocorticoids in humans[J]. Proc Natl Acad Sci U S A, 1992, 89: 1458-1462. DOI: 10.1073/pnas.89.4.1458
    [7]
    Curnow KM, Mulatero P, Emeric-Blanchouin N, et al. The amino acid substitutions Ser288Gly and Val320Ala convert the cortisol producing enzyme, CYP11B1, into an aldoster-one producing enzyme[J]. Nat Struct Biol, 1997, 4: 32-35. DOI: 10.1038/nsb0197-32
    [8]
    Feldman D, Funder JW. The binding of 18-hydroxydeoxycorticosterone and 18-hydroxycorticosterone to mineralocorticoid and glucocorticoid receptors in the rat kidney[J]. Endocrinology, 1973, 92: 1389-1396. DOI: 10.1210/endo-92-5-1389
    [9]
    Lapworth R, Short F, James VH. 18-Hydroxycorticosterone as a marker for primary hyperaldosteronism[J]. Ann Clin Biochem, 1989, 26: 227-232. DOI: 10.1177/000456328902600303
    [10]
    Biglieri EG, Schambelan M. The significance of elevated levels of plasma 18-hydroxycorticosterone in patients with primary aldosteronism[J]. J Clin Endocrinol Metab, 1979, 49: 87-91. DOI: 10.1210/jcem-49-1-87
    [11]
    Kem DC, Tang K, Hanson CS, et al. The prediction of anatomical morphology of primary aldosteronism using serum 18-hydroxycorticosterone levels[J]. J Clin Endocrinol Metab, 1985, 60: 67-73. DOI: 10.1210/jcem-60-1-67
    [12]
    Gomez-Sanchez CE, Leon LM, Gomez-Sanchez EP. Biotin-hydrazide derivatives for the development of steroid enzyme-linked immunoassays[J]. J Steroid Biochem Mol Biol, 1992, 43: 523-527. DOI: 10.1016/0960-0760(92)90239-F
    [13]
    Morra DCS, Veglio F, Mulatero P, et al. A time-resolved fluoroimmunoassay for 18-oxocortisol and 18-hydroxycortisol. Development of a monoclonal antibody to 18-oxocortisol[J]. J Steroid Biochem Mol Biol, 2002, 82: 83-88. DOI: 10.1016/S0960-0760(02)00142-5
    [14]
    Mulatero P, di Cella SM, Monticone S, et al. 18-hydroxycorticosterone, 18-hydroxycortisol, and 18-oxocortisol in the diagnosis of primary aldosteronism and its subtypes[J]. J Clin Endocrinol Metab, 2012, 97: 881-889. DOI: 10.1210/jc.2011-2384
    [15]
    Phillips JL, Walther MM, Pezzullo JC, et al. Predictive value of preoperative tests in discriminating bilateral adrenal hyperplasia from an aldosterone-producing adrenal adenoma[J]. J Clin Endocrinol Metab, 2000, 85: 4526-4533. DOI: 10.1210/jcem.85.12.7086
    [16]
    Auchus RJ, Chandler DW, Singeetham S, et al. Measure-ment of 18-hydroxycorticosterone during adrenal vein samp-ling for primary aldosteronism[J]. J Clin Endocrinol Metab, 2007, 92: 2648-2651. DOI: 10.1210/jc.2006-2631
    [17]
    Makowski N, Burckhardt BB. Enabling insights into the maturation of the renin-angiotensin-aldosterone system in children-Development of a low-volume LC-MS assay for the simultaneous determination of aldosterone, its precursor, and main metabolite[J]. Steroids, 2019, 148: 73-81. DOI: 10.1016/j.steroids.2019.04.009
    [18]
    Ojima M, Kambegawa A. Plasma concentrations of 18-hydroxy-11-deoxycorticosterone and 18-hydroxycorticosterone simultaneously measured in normal subjects and adrenocor-tical disorders[J]. Tohoku J Exp Med, 1980, 132: 75-85. DOI: 10.1620/tjem.132.75
    [19]
    尹逸丛, 禹松林, 王丹晨, 等. 液相色谱串联质谱检测尿醛固酮方法的建立[J]. 中华检验医学杂志, 2018, 41: 481-486. DOI: 10.3760/cma.j.issn.1009-9158.2018.06.015

    Yin YC, Yu SL, Wang DC, et al. Quantification of human urine aldosterone by LC-MS/MS[J]. Zhonghua Jianyan Yixue Zazhi, 2018, 41: 481-486. DOI: 10.3760/cma.j.issn.1009-9158.2018.06.015
  • Related Articles

    [1]CHEN Yingyu, WANG Ou, XING Xiaoping. Genetic and Clinical Characteristics of Pediatric Primary Hyperparathyroidism[J]. Medical Journal of Peking Union Medical College Hospital. DOI: 10.12290/xhyxzz.2024-0731
    [2]ZHANG Shan, LIU Jie. Interpretation of NCCN Clinical Practice Guidelines for Primary Cutaneous Lymphomas (Version 1.2024) Based on the Current Diagnosis and Treatment Status of China[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(5): 1029-1037. DOI: 10.12290/xhyxzz.2024-0605
    [3]LIU Yimin, CHEN Libo, LIU Yu, WANG Zhenghua, HU Nan, LI Congxin, ZHU Shikun, ZHANG Zheng, JING Hongli, HUO Li. Clinical Values of 99mTc-MIBI Pinhole Dual-phase and Parallel-hole SPECT/CT for Preoperative Localization in Patients with Primary Hyperparathyroidism[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(4): 774-780. DOI: 10.12290/xhyxzz.2023-0164
    [4]Chinese Urological Doctor Association Adrenal Hypertension Surgery Collaborative Organization Adrenal Group, Chinese Society of Endocrinology PET group, Chinese Society of Nuclear Medicine. Consensus on Clinical Application of the CXCR4-targeted Imaging in the Diagnosis of Primary Aldosteronism(2022)[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(6): 986-991. DOI: 10.12290/xhyxzz.2022-0584
    [5]AN Ran, XIA Song, SUN Yuguang, CHANG Kun, XIN Jianfeng, WANG Tingting, SHEN Wenbin. Clinical Characteristics of Patients with Primary Chylothorax Failed in Treatment of Thoracic Duct Ligation[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(3): 468-472. DOI: 10.12290/xhyxzz.2022-0148
    [6]LIU Jie, LUO Yi-xin, LIU Zhao-rui, LIU Yue-hua, ZHANG Wei, LU Zhao-hui. WHO-EORTC Classification of Primary Cutaneous Lymphomas:Updates and Interpretation[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(6): 698-702. DOI: 10.3969/j.issn.1674-9081.2020.06.011
    [7]Ming CUI, Ou WANG, Quan LIAO. Advances in Diagnosis and Surgical Treatment of Primary Hyperparathyroidism[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(4): 395-401. DOI: 10.3969/j.issn.1674-9081.2020.04.007
    [8]Jian-hua DENG, Han-zhong LI. Diagnosis and Clinical Treatment of Primary Adrenal Lymphoma[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(1): 91-95. DOI: 10.3969/j.issn.1674-9081.20170164
    [9]Wei WU, Yi-ning WANG, Jing-wen DAI, Zheng-yu JIN, Shu-yang ZHANG. New Clinical Diagnostic Pathway of Primary Cardiomyopathy: from High-resolution Imaging to Molecular Precision Medicine[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(1): 6-10. DOI: 10.3969/j.issn.1674-9081.2019.01.002
    [10]Jie LIU, Yue-ping ZENG, Chun-xia HE, Qin LONG, Hong-zhong JIN, Qiu-ning SUN. Corticosteroids plus Intravenous Immunoglobulin in the Treatment of 7 Cases with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis[J]. Medical Journal of Peking Union Medical College Hospital, 2012, 3(4): 381-385. DOI: 10.3969/j.issn.1674-9081.2012.04.004
  • Cited by

    Periodical cited type(0)

    Other cited types(1)

Catalog

    Article Metrics

    Article views (757) PDF downloads (78) Cited by(1)
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close